Prepare for your consultation by: Documenting your current rheumatoid arthritis symptoms, disease activity, and treatment history Listing all current medications, including DMARDs, biologics, corticosteroids, and analgesics Noting any comorbidities, particularly diabetes, obesity, cardiovascular disease, or gastrointestinal conditions Being honest about your treatment goals and what has prompted interest in GLP-1 therapy Questions to discuss with your doctor : What is the current evidence for GLP-1 use in rheumatoid arthritis
As a synthetic analog of growth hormonereleasing hormone (GHRH), Tesamorelin is commonly examined in research for its interaction with GHRH receptors and its downstream influence on endocrine signaling pathways associated with endogenous growth hormone regulation and insulin-like growth factor-1 (IGF-1) activity
Glow Up Copper Peptide Patches provide targeted, sustained delivery of GHK-Cu to the skin, help with how to reduce melanin production, fade dark spots, and promote an even skin tone
By the end of week four, we know whether the patient tolerates the GLP-1 piece and we have a stable dose to layer onto
A peptide is a chain of amino acids held together by peptide bonds, and those bonds are precisely what digestive enzymes (pepsin, trypsin) are built to cut, with the acidic stomach environment finishing the job so an oral peptide is largely destroyed before it can be absorbed, which is why injection is the default
Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are the FDA-approved obesity GLP-1s
